CG
RGEN icon

Cynosure Group’s Repligen RGEN Stock Holding History

Cynosure Group’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,421
Closed -$457K – 503
2025
Q3 		$457K Hold
3,421
– – 0.05% 229
2025
Q2 		$426K Buy
3,421
+1,153
+51% +$147K 0.05% 243
2025
Q1 		$289K Buy
2,268
+276
+14% +$42.5K 0.04% 361
2024
Q4 		$287K Sell
1,992
-885
-31% -$127K 0.04% 307
2024
Q3 		$428K Sell
2,877
-147
-5% -$21.1K 0.06% 183
2024
Q2 		$381K Buy
3,024
+1,372
+83% +$215K 0.06% 247
2024
Q1 		$304K Buy
+1,652
New +$315K 0.05% 296

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Cynosure Group's RGEN Position: Q4 2025 in Review

Cynosure Group sold out of Repligen (RGEN) in Q4 2025, closing a stake of 3,421 shares — an estimated $457K sold.

Cynosure Group first reported a position in RGEN in Q1 2024 and held it in 7 quarters. The position peaked at $457K in Q3 2025. 474 funds tracked by Wall St. Rank hold RGEN as of Q4 2025.

  • Cynosure Group reported no remaining Repligen position as of Q4 2025 after selling out during the quarter.
  • Cynosure Group sold 3,421 Repligen shares in Q4 2025, an estimated $457K.
  • Cynosure Group first reported a position in Repligen in Q1 2024 and held it in 7 quarters.
  • Cynosure Group's Repligen position peaked at $457K in Q3 2025.
  • 474 funds tracked by Wall St. Rank held Repligen as of Q4 2025.

Based on Cynosure Group's 13F filing for Q4 2025, filed 17 Feb 2026.